Skip to main content
Premium Trial:

Request an Annual Quote

Bruker, Premier Biosoft Enter Reselling Agreement for SimLipid, SimMet Software

NEW YORK(GenomeWeb) – Premier Biosoft and Bruker said today that they have entered a reselling agreement under which Bruker will co-market and resell Premier's SimLipid and SimMet informatics software. 

SimLipid and SimMet are intended for mass spec-based analysis of, respectively, lipids and metabolites and facilitate automated LC-MS and MS/MS data processing workflows and identification and quantitation of these analytes, the companies said.

"With this collaboration, we hope to address several of the challenges in advanced biomarker and translational research," Aiko Barsch, market manager at Bruker, said in a statement.

Financial and other terms of the agreement were not disclosed.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.